2022. Serum interleukin-6 is associated with hypocalcemia, hypoferritinemia and hyperkalemia in end-stage renal disease patients. Italian Journal of Medicine. 16, 1 (Dec. 2022). DOI:https://doi.org/10.4081/itjm.2022.1550.